JP Patent

JP7093871B2 — 細胞反応性、長時間作用型または標的化コンプスタチン類似体ならびに関係する組成物および方法

Assigned to Apellis Pharmaceuticals Inc · Expires 2022-06-30 · 4y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7093871B2
Jurisdiction: JP
Classification: —
Expires: 2022-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Apellis Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.